These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study]. Bayerdörffer E, Kasper G, Pirlet T, Sommer A, Ottenjann R. Dtsch Med Wochenschr; 1987 Sep 11; 112(37):1407-11. PubMed ID: 3304929 [Abstract] [Full Text] [Related]
13. [Impact of the anti-Helicobacter therapy on the life quality of patients with duodenal ulcers]. Guseĭnzade MG. Eksp Klin Gastroenterol; 2005 Sep 11; (5):22-7. PubMed ID: 16518910 [No Abstract] [Full Text] [Related]
15. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP. Helicobacter; 2004 Apr 11; 9(2):124-9. PubMed ID: 15068413 [Abstract] [Full Text] [Related]